Therapy News and Research

RSS

Scientists identify enzyme that could lead to better treatment of Alzheimer's disease

St. Jude Children's Research Hospital scientists have identified an enzyme that can halt or possibly even reverse the build-up of toxic protein fragments known as plaques in the brains of mice with Alzheimer's disease. The research appeared in a recent edition of the scientific journal Nature Communications.

3 Dec 2013

Obese patients receive needless respiratory treatment

Research from the USA shows that a substantial proportion of obese patients are prescribed bronchodilators, even after spirometry indicates a lack of lung obstruction.

3 Dec 2013

Investigational c-Met inhibitor shows early promise in NSCLC

A first-in-class drug that inhibits c-Met, a receptor tyrosine kinase, has demonstrated good tolerability when combined with erlotinib in the treatment of Japanese patients with advanced/metastatic non-small-cell lung cancer.

3 Dec 2013

LabCorp's HCV GenoSure NS3/4 test now available for Q80K polymorphism screening

Laboratory Corporation of America Holdings announced today the immediate availability of an enhanced version of its HCV GenoSure NS3/4, a drug resistance test that screens for the Q80K polymorphism. Q80K is a naturally occurring polymorphism that develops in certain strains of HCV, making the virus less susceptible to Janssen Therapeutics' OLYSIO (simeprevir), which was recently approved by the U.S. Food and Drug Administration for the treatment of certain adult patients diagnosed with genotype 1chronic hepatitis C.

3 Dec 2013

Biotest, EpiVax partner to develop novel, non-immunogenic Factor VIII for hemophilia treatment

Biotest AG, Dreieich, Germany and EpiVax, Inc., Providence, Rhode Island, USA are pleased to announce a new Collaborative Research Agreement. With this collaboration a novel, non-immunogenic Factor VIII should be developed.

3 Dec 2013

Study supports use of EndoBarrier Therapy for patients with type 2 diabetes and obesity

GI Dynamics, Inc. today announced findings from a new meta-analysis which describes the increasingly robust efficacy and safety profile of EndoBarrier Therapy, an endoscopically-delivered device therapy approved for the treatment of type 2 diabetes and obesity.

3 Dec 2013

TxCell receives Manufacturing Accreditation from ANSM for cell therapy production site in France

TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today that it received a Manufacturing Accreditation delivered by the French National Agency for Drug Safety. The status has been received for its cell therapy production site in Besançon, France.

3 Dec 2013

CUMC researchers make new breakthrough in regenerative medicine

As fast-growing biotech company Rainbow Coral Corp. works to deliver new cutting-edge treatments in the field of regenerative medicine, a major new breakthrough could soon lead to growing new lungs for patients in a laboratory.

3 Dec 2013

EORTC hosts joint session with ESTRO to focus on latest developments in soft tissue sarcoma treatment

The EORTC will host a joint session with ESTRO at ESTRO 33 focusing on current developments in soft tissue sarcoma treatment. It will take place from 14:30- 16:00 on Monday, 07 April 2014 in Vienna, Austria and will be co-chaired by Professors Jean-Yves Blay of the Centre Leon Berard in Lyon, France and past EORTC President and Philippe Maingon of the Centre Georges-Fran-ois-Leclerc in Dijon, France, and Chair of the EORTC Radiation Oncology Group.

3 Dec 2013

Patients with RA today have easier time with daily living than patients diagnosed two decades ago

New research reveals that patients with rheumatoid arthritis today have an easier time with daily living than patients diagnosed two decades ago. According to results of the study published in Arthritis Care & Research, a journal of the American College of Rheumatology, anxiety, depressed mood and physical disability have been cut in half over the last 20 years. Researchers believe a reduction in disease activity is partly responsible for this positive change.

3 Dec 2013

Researchers offer promise of strategy for curing HIV infection

Researchers have used radioimmunotherapy (RIT) to destroy remaining human immunodeficiency virus (HIV)-infected cells in the blood samples of patients treated with antiretroviral therapy, offering the promise of a strategy for curing HIV infection. Results of the study were presented today at the annual meeting of the Radiological Society of North America (RSNA).

3 Dec 2013

First Nations adults with diabetes more likely to face risk of end-stage kidney disease

First Nations adults with diabetes have more than double the risk of end-stage kidney disease compared with non-First Nations adults, found a new study in CMAJ (Canadian Medical Association Journal).

3 Dec 2013

Evidence reveals bronchial thermoplasty has long-term benefit for asthma patients

The beneficial effects of bronchial thermoplasty, a non-pharmacologic treatment for asthma, last at least five years, according to researchers at National Jewish Health and other institutions.

3 Dec 2013

Alliance HealthCare Services, ONRAD form strategic affiliation to provide quality services to customers

Alliance HealthCare Services, Inc., a leading national provider of radiology and radiation therapy services, and ONRAD, Inc., a full service radiology provider, have agreed to establish a strategic affiliation to develop and support opportunities to further enhance access to the quality services each company provides to its customers.

2 Dec 2013

Four-drug regimen shows first-line efficacy in advanced NSCLC

A four-drug combination of cetuximab, bevacizumab, carboplatin, and paclitaxel is effective and has acceptable safety as a first-line treatment for advanced non-small-cell lung cancer, US researchers report.

2 Dec 2013

Vitamin D status optimization could cut pneumonia cases

A large US population-based study confirms that serum 25-hydroxyvitamin D levels are associated with the risk for community-acquired pneumonia.

2 Dec 2013

New biomarkers to improve diagnostics of prostate cancer

New biomarkers will improve diagnostics of endemic diseases in future, such as prostate cancer. Their mission: to recognize the tumor earlier and classify it more precisely - thereby helping avoid unnecessary operations.

2 Dec 2013

New multinational survey to investigate early conversations between physicians and T2D people

Boehringer Ingelheim and Eli Lilly and Company today announced the launch of the largest multinational survey to investigate early conversations between physicians and people living with Type 2 Diabetes. The survey was developed in partnership with the International Diabetes Federation and will include more than 10,000 people with T2D and more than 6,500 treating-physicians across 26 countries worldwide

2 Dec 2013

PRP therapy improves functionality of tendons in athletes with degenerative disease

Ultrasound-guided delivery of platelet-rich plasma improves functionality and reduces recovery time in athletes with degenerative disease in their tendons, according to a study being presented today at the annual meeting of the Radiological Society of North America.

2 Dec 2013

Stroke patients report improvements in their motor function using novel rehabilitation device

Using a novel stroke rehabilitation device that converts an individual's thoughts to electrical impulses to move upper extremities, stroke patients reported improvements in their motor function and ability to perform activities of daily living. Results of the study were presented today at the annual meeting of the Radiological Society of North America.

2 Dec 2013

Therapy News and Research

Scientists identify enzyme that could lead to better treatment of Alzheimer's disease

Obese patients receive needless respiratory treatment

Investigational c-Met inhibitor shows early promise in NSCLC

LabCorp's HCV GenoSure NS3/4 test now available for Q80K polymorphism screening

Biotest, EpiVax partner to develop novel, non-immunogenic Factor VIII for hemophilia treatment

Study supports use of EndoBarrier Therapy for patients with type 2 diabetes and obesity

TxCell receives Manufacturing Accreditation from ANSM for cell therapy production site in France

CUMC researchers make new breakthrough in regenerative medicine

EORTC hosts joint session with ESTRO to focus on latest developments in soft tissue sarcoma treatment

Patients with RA today have easier time with daily living than patients diagnosed two decades ago

Researchers offer promise of strategy for curing HIV infection

First Nations adults with diabetes more likely to face risk of end-stage kidney disease

Evidence reveals bronchial thermoplasty has long-term benefit for asthma patients

Alliance HealthCare Services, ONRAD form strategic affiliation to provide quality services to customers

Four-drug regimen shows first-line efficacy in advanced NSCLC

Vitamin D status optimization could cut pneumonia cases

New biomarkers to improve diagnostics of prostate cancer

New multinational survey to investigate early conversations between physicians and T2D people

PRP therapy improves functionality of tendons in athletes with degenerative disease

Stroke patients report improvements in their motor function using novel rehabilitation device

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News